Adam Kaplin

Company: Mira Pharmaceuticals, Inc

Job title: President & Chief Scientific Officer

Seminars:

A Novel Synthetic THC Analog That Diminishes Pain & Anxiety While Enhancing Cognition 11:30 am

Understanding the process of development and testing of novel cannabinoid analogs that optimizes side effect properties Reviewing the strengths and vulnerabilities of THC as a therapeutic drug Sharing novel, dramatic cognitive enhancing potential of novel cannabinoids based on their pharmacodynamic propertiesRead more

day: Day Two